GEN Exclusives

More »

Best of the Web

More »
Dec 01, 2012 (Vol. 32, No. 21)

Cerebellar Development Transcriptome Database
  • Nice user interface, good expression data search
  • Java displays slow to load

The cerebellum is a key brain region for motor control and coordination and its microcircuitry is a much-studied system in neuroscience. For researchers interested in understanding how the mammalian cerebellum develops, the Cerebellar Development Transcriptome Database (CDT-DB) is a great online resource. The website offers access to a database of spatiotemporal gene expression profiles for genes expressed in the developing cerebellum, drawing upon data from a variety of experimental approaches including in situ hybridization, cDNA microarrays, and RT-PCR. The “about” section of the website provides site visitors with a comprehensive overview of the CDT-DB Project, the database itself, and the methods used to collect data. While users can use the gene search option to search for individual genes, a perhaps more useful feature is the expression data search, wherein users can search for one or many of the following parameters: spatial expression, developmental temporal expression pattern, brain distribution, and brain specificity.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »